Free Biopharma Daily Stock Updates - 03/04/22
$XBI $83.90 | -3.17% Pipeline Updates $CHRS +2.5% Coherus and Junshi Biosciences Announce Positive Results from Phase 3 Esophageal...
top of page
BPIQ Blog
Mar 3, 20221 min read
Free Biopharma Daily Stock Updates - 03/03/22
$XBI $86.65| -2.99% Pipeline Updates $GLSI -3.3% Greenwich LifeSciences Provides Updates on Upcoming Phase III Clinical Trial, Patent...
Mar 3, 20222 min read
Smid-cap Biopharma Companies Acquired 2022 - Updated July 2022
(Last updates 7/21/22) On BPIQ.com we report when companies have been acquired and whether company assets are still in the database...
Mar 2, 20221 min read
Free Biopharma Daily Stock Updates - 03/02/22
$XBI $89.32 | +0.26% Pipeline Updates $TCDA +4.9% Tricida Provides Update on Timing of Top-Line Data for the VALOR-CKD Trial Based on...
Mar 2, 20222 min read
Free Biopharma Daily Stock Updates - 03/01/22
$XBI $89.09 | Pipeline Updates $FNCH Finch Therapeutics Provides an Update on its Phase 3 Trial of CP101 in Recurrent C. difficile...
Feb 28, 20223 min read
Free Biopharma Daily Stock Updates - 02/28/22
$XBI $89.83 | +0.03% Covid Updates $NVAX +2.1% Novavax Announces Extended Durability of Protection Against Infection and Disease in...
Feb 25, 20222 min read
Biopharma Pulse - 2/21-2/25 Week in Review
As we reach the end of the month, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves...
Feb 25, 20221 min read
Free Biopharma Daily Stock Updates - 02/25/22
$XBI $89.80 | +0.9% Pipeline Updates $RETA +2.2% Reata Pharmaceuticals Receives Complete Response Letter From The FDA for Bardoxolone...
Feb 25, 20222 min read
Free Biopharma Daily Stock Updates - 02/24/22
$XBI $89.00 | +8.67% Covid Updates $TFFP TFF Pharmaceuticals Announces Inhaled Niclosamide Significantly Inhibits Viral Replication of...
Feb 24, 20221 min read
Free Biopharma Daily Stock Updates - 02/23/22
$XBI $85.10 | -4.04% Covid Updates $NVAX -7.4% Novavax Announces Shipments of its COVID-19 Vaccine to European Union Member States....
Feb 22, 20222 min read
Free Biopharma Daily Stock Updates - 02/22/22
$XBI $88.68 | -0.79% Covid Updates $SRNE -2.5% Sorrento Announces COVISHIELD (STI-9167) Antibody Strongly Neutralizes BA.2 Omicron...
Feb 20, 20221 min read
BLU - Bull Thesis
BULL THESIS BLU overall corporate and executive summary ~$380M in cash (including $150M offering about to close) Yrs of cash Should cover...
Feb 18, 20221 min read
Free Biopharma Daily Stock Updates - 02/18/22
$XBI $89.39 | -1.35% Pipeline Updates $CDAK -5.0% Data from Codiak’s exoASO™-STAT6 Preclinical Development Program for the Treatment of...
Feb 18, 20222 min read
Biopharma Pulse - 2/14-2/18 Week in Review
As we reach the middle of the month, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly...
Feb 17, 20221 min read
Free Biopharma Daily Stock Updates - 02/17/22
$XBI $90.61 | -4.3% Covid Updates $NVAX -3.6% Health Canada Authorizes Novavax COVID-19 Vaccine source Pipeline Updates $AGIO -5.2%...
Feb 16, 20222 min read
Free Biopharma Daily Stock Updates - 02/16/22
$XBI $94.65 | -1.04% Covid Updates $ENTA -2.1% Enanta Pharmaceuticals Doses First Subject in a Phase 1 Clinical Study of EDP-235, its...
Feb 15, 20222 min read
Free Biopharma Daily Stock Updates - 02/15/22
$XBI $95.64 | +4.2% Covid Updates $BNTX +5.8% BioNTech to Join High-level Meeting with Partners in Marburg and to Hold Press Conference...
Feb 14, 20222 min read
Free Biopharma Daily Stock Updates - 02/14/22
$XBI $91.81 | -1.7% Covid Updates $NVAX -11.4% Novavax Files for Conditional Marketing Authorization of COVID-19 Vaccine in Switzerland....
Feb 11, 20222 min read
Free Biopharma Daily Stock Updates - 02/11/22
$XBI $93.35 | 1% Covid Updates $GILD Phase 2/3 Interim Data Evaluating the Safety, Tolerability and Clinical Outcomes of Veklury®...
Feb 11, 20221 min read
Biopharma Pulse - 2/7-2/11 Week in Review
As February begins, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page